High-mobility Group B1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE) Expression in Canine Lymphoma

被引:1
作者
Sterenczak, Katharina A. [1 ,2 ,3 ]
Joetzke, Alexa E. [1 ,2 ]
Willenbrock, Saskia [1 ,2 ,3 ]
Eberle, Nina [1 ,2 ]
Lange, Sandra [4 ]
Junghanss, Christian [4 ]
Nolte, Ingo [1 ,2 ]
Bullerdiek, Joern [1 ,2 ,3 ]
Simon, Daniela [1 ,2 ]
Escobar, Hugo Murua [1 ,2 ]
机构
[1] Univ Vet Med Hannover, Small Anim Clin, D-30559 Hannover, Germany
[2] Univ Vet Med Hannover, German Res Fdn SFB Transregio 37, D-30559 Hannover, Germany
[3] Univ Bremen, Ctr Human Genet, D-28359 Bremen, Germany
[4] Univ Rostock, Div Med, Dept Haematol Oncol, D-18057 Rostock, Germany
关键词
Canine lymphoma; HMGB1; RAGE; ENDOTHELIAL GROWTH-FACTOR; NON-HODGKIN-LYMPHOMA; BONE-MARROW ANGIOGENESIS; TOLL-LIKE RECEPTORS; TUMOR ANGIOGENESIS; PROGNOSTIC VALUE; LEUKEMIA; MYELOFIBROSIS; PROTEINS; SPECTRUM;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Canine lymphoma is a commonly occurring, spontaneously developing neoplasia similar to human non-Hodgkin's lymphoma and, thus, is used as a valuable model for human malignancy. HMGB1 and RAGE are strongly associated with tumour progression and vascularisation. Consequently, deregulated RAGE and HMGB1 may play an important role in the mechanisms involved in lymphoma progression. Materials and Methods: Expression patterns of HMGB1 and RAGE were analysed in 22 canine lymphoma and three canine non-neoplastic control samples via real time PCR and canine beta-glucuronidase gene (GUSB) as endogenous control. Results: HMGB1 was up-regulated in the neoplastic samples, while RAGE expression remained inconspicuous. Conclusion: This study demonstrated similar mechanisms in lymphoma progression in humans and dogs due to overexpression of HMGB1, which was described in human lymphomas. RAGE remained stable in terms of expression indicating that the extracellular HMGB1-induced effects are regulated by HMGB1 itself
引用
收藏
页码:5043 / 5048
页数:6
相关论文
共 34 条
[1]  
Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084
[2]   Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma [J].
Bertolini, F ;
Paolucci, M ;
Peccatori, F ;
Cinieri, S ;
Agazzi, A ;
Ferrucci, PF ;
Cocorocchio, E ;
Goldhirsch, A ;
Martinelli, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) :504-509
[3]   Development and evaluation of canine reference genes for accurate quantification of gene expression [J].
Brinkhof, Bas ;
Spee, Bart ;
Rothuizen, Jan ;
Penning, Louis C. .
ANALYTICAL BIOCHEMISTRY, 2006, 356 (01) :36-43
[4]   Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma [J].
Culmsee, K ;
Simon, D ;
Mischke, R ;
Nolte, I .
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2001, 48 (04) :199-206
[5]   Cloning and characterization of the canine receptor for advanced glycation end products [J].
Escobar, HM ;
Soller, JT ;
Sterenczak, KA ;
Sperveslage, JD ;
Schlueter, C ;
Burchardt, B ;
Eberle, N ;
Fork, M ;
Nimzyk, R ;
Winkler, S ;
Nolte, I ;
Bullerdiek, J .
GENE, 2006, 369 :45-52
[6]   Molecular characterization of the canine HMGB1 [J].
Escobar, HM ;
Meyer, B ;
Richter, A ;
Becker, K ;
Flohr, AM ;
Bullerdiek, J ;
Nolte, I .
CYTOGENETIC AND GENOME RESEARCH, 2003, 101 (01) :33-38
[7]  
Gough A., 2004, Breed Predispositions to Disease in Dogs and Cats
[8]   Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays [J].
Hsieh, HL ;
Schäfer, BW ;
Sasaki, N ;
Heizmann, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 307 (02) :375-381
[9]  
Hussong JW, 2000, BLOOD, V95, P309
[10]   Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity [J].
Lundberg, LG ;
Lerner, R ;
Sundelin, P ;
Rogers, R ;
Folkman, J ;
Palmblad, J .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (01) :15-19